{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:26:00Z","timestamp":1769109960435,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis Supplements"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.atherosclerosissup.2005.09.005","type":"journal-article","created":{"date-parts":[[2005,11,5]],"date-time":"2005-11-05T13:48:18Z","timestamp":1131198498000},"page":"13-19","source":"Crossref","is-referenced-by-count":33,"title":["Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination"],"prefix":"10.1016","volume":"6","author":[{"given":"Anthony J.","family":"Comerota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication","volume":"344","author":"Hiatt","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib2","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib5","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.ATV.18.12.1942","article-title":"Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication","volume":"18","author":"Elam","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0741-5214(98)70357-X","article-title":"Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease","volume":"27","author":"Money","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib7","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1046\/j.1532-5415.2002.50604.x","article-title":"Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials","volume":"50","author":"Regensteiner","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosissup.2005.09.005_bib8","first-page":"12","article-title":"Two doses of cilostazol versus placebo in the treatment of claudication: results of a randomized, multicenter trial","volume":"98","author":"Strandness","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0741-5214(03)01029-2","article-title":"Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time","volume":"38","author":"Wilhite","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib10","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.CIR.0000128518.26834.93","article-title":"Atherosclerotic vascular disease conference: Writing Group I: epidemiology","volume":"109","author":"Pasternak","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib11","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1161\/01.CIR.94.11.3026","article-title":"Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review","volume":"94","author":"Weitz","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib12","unstructured":"American Cancer Society. Cancer facts and figures 2005. Available at: http:\/\/www.cancer.org. Accessed September 2, 2005."},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0741-5214(89)70041-0","article-title":"Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study","volume":"9","author":"Howell","year":"1989","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jvs.2003.09.029","article-title":"Patency and limb salvage rates after distal revascularization to unclampable calcified outflow arteries","volume":"39","author":"Ballotta","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0741-5214(90)90338-B","article-title":"Treatment of failed lower extremity bypass grafts with new autogenous vein bypass grafting","volume":"11","author":"Edwards","year":"1990","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib17","first-page":"118","article-title":"Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease","volume":"12","author":"Dormandy","year":"1999","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1532-5415.1999.tb05208.x","article-title":"Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice","volume":"47","author":"Ness","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9149(03)00632-5","volume":"92","author":"Sukhija","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/ejvs.2002.2008","article-title":"Leg blood flow and long-term cardiovascular prognosis in men with typical and atypical intermittent claudication","volume":"26","author":"\u00d6gren","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9343(96)80077-5","article-title":"Antiplatelet therapy","volume":"101","author":"Schafer","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy. Part I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib24","doi-asserted-by":"crossref","unstructured":"D\u00f6rffler-Melly J, B\u00fcller HR, Koopman MM, Prins MH, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery (Cochrane review). In: The Cochrane Library, Issue 2. Chichester, UK: John Wiley and Sons Ltd.; 2004.","DOI":"10.1002\/14651858.CD000535"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjmed.2004.01.014","article-title":"Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis","volume":"116","author":"Schleinitz","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.STR.0000110221.54366.49","article-title":"Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events","volume":"35","author":"Ringleb","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09537105310001645960","article-title":"The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease","volume":"15","author":"Jagroop","year":"2004","journal-title":"Platelets"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib30","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/01.CIR.101.24.2823","article-title":"Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans","volume":"101","author":"Cadroy","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00005344-200204000-00008","article-title":"Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation","volume":"39","author":"D\u00f6rr","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1002658","article-title":"A critical reappraisal of the bleeding time","volume":"16","author":"Rodgers","year":"1990","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib33","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood.V84.10.3363.3363","article-title":"Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding","volume":"84","author":"De Caterina","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib34","first-page":"353","article-title":"The clinical usefulness of the preoperative bleeding time","volume":"120","author":"Gerwitz","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.atherosclerosissup.2005.09.005_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5223(19)34348-X","article-title":"Predictors of excessive blood use after coronary artery bypass grafting","volume":"98","author":"Ferraris","year":"1989","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Atherosclerosis Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568805000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568805000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T17:54:08Z","timestamp":1586541248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567568805000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1567568805000693"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2005.09.005","relation":{},"ISSN":["1567-5688"],"issn-type":[{"value":"1567-5688","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}